Genpact Named a Leader in Life Sciences Digital Services for Mid-Market Enterprises in 2024 Everest Group PEAK Matrix® Assessment
Rhea-AI Summary
Genpact (NYSE: G) has been named a Leader in Everest Group's inaugural Life Sciences Digital Services for Mid-Market Enterprises 2024 PEAK Matrix® Assessment. This recognition highlights Genpact's expertise in delivering innovative solutions to mid-market life sciences companies. The assessment evaluated 26 global providers based on vision, capability, and market impact.
Genpact's leadership is underpinned by excellence in key services, including:
- Data Analytics and Insights: AI-powered analytics for better decision-making
- Supply Chain Resilience: Optimizing the entire value chain
- Regulatory Compliance: Navigating regulatory complexity
- Patient-Centric Experiences: Enhancing patient engagement and outcomes
This recognition validates Genpact's commitment to improving global health by accelerating time-to-market for drugs and devices.
Positive
- Recognized as a Leader in Everest Group's Life Sciences Digital Services for Mid-Market Enterprises 2024 PEAK Matrix® Assessment
- Demonstrated excellence in delivering key services such as data analytics, supply chain management, regulatory compliance, and patient-centric solutions
- Global client presence established through creative client engagement and innovative commercial constructs
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, G declined 0.74%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Recognition highlights Genpact's commitment to delivering personalized support and innovative solutions to mid-market life sciences organizations
"Amid economic uncertainty, disrupted supply chains, and high customer expectations, it's more important than ever for life sciences companies to focus on AI innovation and operational resilience," said Sanjiv Tandon, Global Business Unit Leader, Life Sciences, Genpact. "Our deep industry expertise and customer-centric approach have made us a trusted partner in delivering transformative outcomes, and this leadership recognition validates our commitment to improving global health by accelerating the time-to-market for drugs and devices."
Everest Group assessed 26 life sciences digital services providers around the globe based on their vision, capability, and market impact. Genpact's leadership is underpinned by its excellence in delivering key services, including:
- Data Analytics and Insights: Leveraging AI-powered analytics to help life sciences companies uncover valuable insights for better decision-making, Genpact's digital solutions help improve patient experiences and outcomes, optimize sales strategies, and enhance marketing efforts.
- Supply Chain Resilience: In an industry where integrated sales and operations planning is critical, Genpact's supply chain management solutions and services optimize the entire value chain, from forecasting and network design to transportation and logistics, mitigating supply chain risks and improving operational efficiency.
- Regulatory Compliance: The regulatory landscape for life sciences continues to evolve, and compliance is essential. Genpact's regulatory affairs services help companies navigate regulatory complexity and compliance.
- Patient-Centric Experiences: With the shift towards patient-centric models, Genpact's advanced analytics and AI-driven customer experience solutions and expertise in digital therapeutics help companies enhance patient engagement, improve adherence, and deliver better health outcomes.
"Mid-market life sciences enterprises face unique challenges that distinguish them from their larger counterparts, necessitating distinct sourcing needs such as client intimacy, agility, and cost-effective innovation to stay competitive. Recognizing these specific needs, providers are tailoring their strategies to offer personalized support and innovative solutions, capitalizing on the increasing mid-market demand," said Durga Ambati, Practice Director, Everest Group. "Genpact's ability to creatively engage clients in strategic conversations, complemented by its willingness to explore innovative commercial constructs, has helped it to establish a global client presence and be recognized as a Leader in Everest Group's Life Sciences Digital Services for Mid-market Enterprises PEAK Matrix® Assessment 2024."
For more information about Genpact's life science solutions and services, visit: https://www.genpact.com/industries/healthcare-and-life-sciences/life-sciences
About Genpact
Genpact (NYSE: G) is a global professional services and solutions firm delivering outcomes that shape the future. Our 125,000+ people across 30+ countries are driven by our innate curiosity, entrepreneurial agility, and desire to create lasting value for clients. Powered by our purpose – the relentless pursuit of a world that works better for people – we serve and transform leading enterprises, including the Fortune Global 500, with our deep business and industry knowledge, digital operations services, and expertise in data, technology, and AI.
Get to know us at genpact.com and on LinkedIn, X, YouTube, and Facebook.
MEDIA CONTACT:
Roopanki Kalra
Genpact Media Relations -
+91 9971634388
roopanki.kalra@genpact.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/genpact-named-a-leader-in-life-sciences-digital-services-for-mid-market-enterprises-in-2024-everest-group-peak-matrix-assessment-302248861.html
SOURCE Genpact
FAQ
What recognition did Genpact (NYSE: G) receive in the life sciences sector?
What key services does Genpact (NYSE: G) offer to mid-market life sciences companies?
How does Genpact (NYSE: G) contribute to improving global health in the life sciences sector?
What factors were considered in Everest Group's assessment of Genpact (NYSE: G)?
